Fractyl Health, Inc. Common Stock (GUTS) Stock Price
GUTSStock
$0.78−26.47%52W
Market Cap$124.77M
P/E—
PEG Ratio—
Div yield—
Beta2.36
GUTS Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)66.90%
Price vs S&P 500 (4W)0.74%
VGM Score22.61
GUTS Earnings Surprise History
Q2 25-0.57est. -0.36
Q3 25-0.71est. -0.30
Q4 25-0.07est. -0.18
Q2 26-0.12est. -0.14
GUTS Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.18
4.18
4.18
4.15
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GUTSFractyl Health, Inc. Common Stock | F | F | C | $0.78 |
| SYKStryker Corporation | C | B | C | $330.59 |
| MMM3M Company | C | D | B | $179.37 |
| BSXBoston Scientific Corp. | C | B | D | $49.86 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.78 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.64 |
| RMDResMed Inc. | C | B | C | $236.59 |
| DXCMDexCom, Inc. | D | B | B | $89.16 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $348.48 |
| SOLVSolventum Corporation | C | C | B | $91.61 |
| BAXBaxter International Inc. | B | D | B | $26.29 |
About Fractyl Health, Inc. Common Stock
Fractyl Health is a metabolic therapeutics company developing treatments for type 2 diabetes and obesity. The company targets organ-level root causes to deliver durable, disease-modifying therapies rather than chronic symptom management.